Diphenylpentane skeleton as a multi-template for steroid skeleton-recognizing receptors/enzymes

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Molecular Pharmacology

Background:

• The 3,3-diphenylpentane (DPP) skeleton is recognized as a potential steroid skeleton substitute.
• Developing novel ligands for nuclear receptors (NRs) and inhibitors for steroid metabolism enzymes is crucial for therapeutic advancements.

Purpose of the Study:

• To demonstrate a multi-template approach using the DPP skeleton for drug discovery.
• To synthesize diverse ligands for nuclear receptors (NRs) and inhibitors of key enzymes involved in steroid metabolism.

Main Methods:

• Utilized the 3,3-diphenylpentane (DPP) scaffold as a core structure.
• Introduced various substituents onto the DPP skeleton to create diverse chemical entities.
• Screened synthesized compounds for activity as ligands for vitamin D receptor (VDR), androgen receptor (AR), and farnesoid X receptor (FXR).
• Evaluated compounds as inhibitors of 5alpha-reductase and HMG-CoA reductase (HMGR).

Main Results:

• Successfully synthesized a library of compounds based on the DPP skeleton.
• Demonstrated the DPP skeleton's utility in generating ligands for VDR, AR, and FXR.
• Identified DPP derivatives as potent inhibitors of 5alpha-reductase and HMGR.
• The multi-template approach proved efficient for creating molecules targeting steroid-related pathways.

Conclusions:

• The 3,3-diphenylpentane (DPP) skeleton is a highly adaptable scaffold for developing novel therapeutic agents.
• This strategy enables the efficient generation of diverse ligands and inhibitors relevant to nuclear receptor modulation and steroid metabolism.
• The DPP-based multi-template approach offers a promising avenue for drug discovery in endocrinology and related fields.